Role of Side Effects, Physician Involvement, and Patient Perception in Non-Adherence with Oral Bisphosphonates
Conclusion
Our findings highlight the importance of low tolerability to non-adherence with osteoporosis therapy and underlines poor patients’ awareness and sub-optimal physicians’ involvement in conveying the importance of this therapy.
Funding
Merck & Co Inc.
Source: Advances in Therapy - Category: Drugs & Pharmacology Source Type: research
More News: Acid Reflux | Actonel | Computers | Databases & Libraries | Drugs & Pharmacology | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Health | Heartburn | Men | Merck | Orthopaedics | Osteoporosis | Risedronate | Study | Women